A randomised double blind placebo-controlled clinical trial to evaluate the effects of Liv-Pro- a food supplement for Non-Alcoholic Fatty Liver Disease
Liv-Pro was well-tolerated with no reported side effects, suggesting its potential as a safe and effective therapeutic option for NAFLD. Continuous administration of Liv-Pro is recommended for sustained efficacy.
Authors
- P.A. Paranagama (ORCID: https://orcid.org/0000-0001-5489-081X)
- Uditha Prabhath Liyanage
- Anchala I. Kuruppu (ORCID: https://orcid.org/0000-0003-1024-9195)
- Aruni Chamika
- Lankani Hettigoda
Institutions
- University of Kelaniya (LK)
- General Sir John Kotelawala Defence University (LK)
- Shri Dharmasthala Manjunatheswara College of Ayurveda and Hospital (IN)
- Rubber Research Institute of Sri Lanka (LK)
Publication Details
- Journal
- Journal of Ayurveda and Integrative Medicine
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1016/j.jaim.2025.101196
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00